Alphavirus vectors for gene expression and vaccines

被引:91
作者
Schlesinger, S
Dubensky, TW
机构
[1] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA
[2] Chiron Technol, Gene Therapy & Vaccines, Emeryville, CA 94608 USA
关键词
D O I
10.1016/S0958-1669(99)00006-3
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Alphavirus expression vectors are finding novel uses in research. They are showing increasing promise as vaccines and are being developed for diagnostic assays of other viruses. Some highlights over the past couple of years include improvements in packaging of replicons, targeting of Sindbis virus replicons, stable cell lines that can be induced to produce replicons, and the isolation of noncytopathic variants of Sindbis virus replicons. Reports that alphavirus vectors can efficiently infect neurons in rat hippocampal slices should increase their use in neurobiological studies.
引用
收藏
页码:434 / 439
页数:6
相关论文
共 31 条
[1]   Noncytopathic Sindbis virus RNA vectors for heterologous gene expression [J].
Agapov, EV ;
Frolov, I ;
Lindenbach, BD ;
Pragai, BM ;
Schlesinger, S ;
Rice, CM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (22) :12989-12994
[2]   Dendritic cells acquire antigen from apoptotic cells and induce class I restricted CTLs [J].
Albert, ML ;
Sauter, B ;
Bhardwaj, N .
NATURE, 1998, 392 (6671) :86-89
[3]   Immunization with recombinant Semliki Forest virus induces protection against influenza challenge in mice [J].
Berglund, P ;
Fleeton, MN ;
Smerdou, C ;
Liljeström, P .
VACCINE, 1999, 17 (05) :497-507
[4]   Outcome of immunization of cynomolgus monkeys with recombinant Semliki Forest virus encoding human immunodeficiency virus type 1 envelope protein and challenge with a high dose of SHIV-4 virus [J].
Berglund, P ;
QuesadaRolander, M ;
Putkonen, P ;
Biberfeld, G ;
Thorstensson, R ;
Liljestrom, P .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1997, 13 (17) :1487-1495
[5]   Enhancing immune responses using suicidal DNA vaccines [J].
Berglund, P ;
Smerdou, C ;
Fleeton, MN ;
Tubulekas, I ;
Liljeström, P .
NATURE BIOTECHNOLOGY, 1998, 16 (06) :562-565
[6]   Humoral, mucosal, and cellular immunity in response to a human immunodeficiency virus type 1 immunogen expressed by a Venezuelan equine encephalitis virus vaccine vector [J].
Caley, IJ ;
Betts, MR ;
Irlbeck, DM ;
Davis, NL ;
Swanstrom, R ;
Frelinger, JA ;
Johnston, RE .
JOURNAL OF VIROLOGY, 1997, 71 (04) :3031-3038
[7]   DNA-based and alphavirus-vectored immunisation with prM and E proteins elicits long-lived and protective immunity against the flavivirus, Murray Valley encephalitis virus [J].
Colombage, G ;
Hall, R ;
Pavy, M ;
Lobigs, M .
VIROLOGY, 1998, 250 (01) :151-163
[8]   A viral vaccine vector that expresses foreign genes in lymph nodes and protects against mucosal challenge [J].
Davis, NL ;
Brown, KW ;
Johnston, RE .
JOURNAL OF VIROLOGY, 1996, 70 (06) :3781-3787
[9]   Identification of mutations in a Sindbis virus variant able to establish persistent infection in BHK cells: The importance of a mutation in the nsP2 gene [J].
Dryga, SA ;
Dryga, OA ;
Schlesinger, S .
VIROLOGY, 1997, 228 (01) :74-83
[10]   Recombinant Semliki Forest virus and Sindbis virus efficiently infect neurons in hippocampal slice cultures [J].
Ehrengruber, MU ;
Lundstrom, K ;
Schweitzer, C ;
Heuss, C ;
Schlesinger, S ;
Gähwiler, BH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (12) :7041-7046